Sanofi India Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Sanofi India Ltd. on BSE

Load latest

Sanofi India Ltd.

02 Jul 2018, 10:35AM

5130.00

0.29%

Company Update

Announcements Under Regulation 30(5) Of LODR

BSE India

As required under regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors has authorised the Managing Director and Chief Financial Officer to determine materiality of an event or information in line with the said Regulations. The Board has also authorised the Company Secretary to disclose such information to the Stock Exchanges....

pdf

Sanofi India Ltd.

11 Jun 2018

5130.00

0.29%

Company Update

Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release - Combiflam Range of Pain Relief Solutions launches Pain Education Campaign We enclose herewith a copy of press release on the above subject, contents of which are self-explanatory for your information and records

pdf

Sanofi India Ltd.

25 May 2018

5130.00

0.29%

Corp. Note

Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Publication of Notice to Shareholders Please find enclosed copies of the notice to shareholders of the Company published today, in newspapers, Business Standard and Sakal.

pdf

Sanofi India Ltd.

09 May 2018

5130.00

0.29%

AGM

Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

BSE India

Sanofi India Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

Sanofi India Ltd.

09 May 2018

5130.00

0.29%

AGM

Annual Report For Financial Year Ended 31St December 2017

BSE India

Pursuant to Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Annual Report for the financial year ended 31st December 2017. The audited financial statements for the said financial year were approved and adopted at the Annual General Meeting of the Company held on 8th May 2018.

pdf

Sanofi India Ltd.

09 May 2018

5130.00

0.29%

AGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Please find enclosed the Scrutinizer's Report on the e-voting conducted from 5th May 2018 to 7th May 2018 and polling conducted at the venue of the Annual General Meeting.

pdf

Sanofi India Ltd.

09 May 2018

5130.00

0.29%

AGM

Summary Of Proceedings Of 62Nd Annual General Meeting Held On 8Th May 2018

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a summary of proceedings of the 62nd Annual General Meeting of the Company held on 8th May 2018 at Hall of Culture, Nehru Centre, Dr. Annie Besant Road, Worli, Mumbai.

pdf

Sanofi India Ltd.

08 May 2018

5130.00

0.29%

Company Update

Change In Chief Financial Officer With Effect From 1St July 2018

BSE India

As required under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company at its meeting held on 8th May 2018 approved appointment of Mr. Charles Billard as Chief Financial Officer and Key Managerial Personnel with effect from 1st July 2018....

pdf

Sanofi India Ltd.

08 May 2018

5130.00

0.29%

Result

Results - Financial Results For Mar 31, 2018

BSE India

We refer to our letter dated 23rd April 2018 informing you of our Board Meeting that was scheduled today. The Meeting of Board of Directors commenced at 11.00 a.m. and concluded at 1.00 p.m. The Board approved unaudited financial results for the quarter ended 31st March 2018. We enclose a copy of the unaudited financial results of the Company for the quarter ended...

pdf

Sanofi India Ltd.

24 Apr 2018

5130.00

0.29%

Corp. Note

Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed copies of the Notice of the Board Meeting of the Company published today, in newspapers, Business Standard and Sakal.

pdf

Is Sanofi India Ltd. worth buying?

295 Votes:

Buy 79.66%

Sell 11.19%

Hold 9.15%